Coral Laboratories [CORALAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Coral Laboratories

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories wins in 6 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCoral LaboratoriesDivi's LaboratoriesBetter
P/E Ratio (TTM)10.4167.57Coral Laboratories
Price-to-Book Ratio0.9310.40Coral Laboratories
Debt-to-Equity Ratio1.770.03Divi's Laboratories
PEG Ratio-0.152.55Coral Laboratories
EV/EBITDA4.6449.66Coral Laboratories
Profit Margin (TTM)17.54%23.89%Divi's Laboratories
Operating Margin (TTM)9.19%25.60%Divi's Laboratories
EBITDA Margin (TTM)9.19%25.60%Divi's Laboratories
Return on Equity12.01%14.64%Divi's Laboratories
Return on Assets (TTM)10.53%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-41.67M$2.15BDivi's Laboratories
Dividend Yield0.29%0.91%Divi's Laboratories
1-Year Return-41.03%-5.14%Divi's Laboratories
Price-to-Sales Ratio (TTM)1.8316.13Coral Laboratories
Enterprise Value$823.11M$1,522.01BDivi's Laboratories
EV/Revenue Ratio0.8115.77Coral Laboratories
Gross Profit Margin (TTM)53.58%60.33%Divi's Laboratories
Revenue per Share (TTM)$286$363Divi's Laboratories
Earnings per Share (Diluted)$50.14$86.82Divi's Laboratories
Beta (Stock Volatility)0.700.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Coral Laboratories vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Coral Laboratories
Divi's Laboratories
Coral Laboratories Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories-0.90%3.35%2.66%-12.43%-19.72%-36.61%
Divi's Laboratories-0.67%2.26%-3.33%-15.42%10.79%-4.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories-41.03%95.66%39.82%8.95%318.43%440.61%
Divi's Laboratories-5.14%63.08%80.80%444.71%1,530.25%8,023.95%

News Based Sentiment: Coral Laboratories vs Divi's Laboratories

Coral Laboratories

News based Sentiment: MIXED

Coral Laboratories experienced a share price increase in October, but longer-term trends remain negative. The board's actions regarding cost audits and leadership appointments suggest a focus on stability and compliance, creating a mixed investment narrative.

View Coral Laboratories News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

Divi's Laboratories reported strong Q3 results, but also faces mixed analyst opinions, recent underperformance, and a shift in technical trends. The company is also taking on new debt, indicating a strategic change. These factors create a complex investment narrative.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Coral Laboratories vs Divi's Laboratories

MetricCORALABDIVISLAB
Market Information
Market Cap i₹1.98B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i622455,187
90 Day Avg. Volume i887395,686
Last Close₹516.55₹5,826.50
52 Week Range₹442.55 - ₹859.00₹4,955.00 - ₹7,071.50
% from 52W High-39.87%-17.61%
All-Time High₹1,190.00 (Jul 24, 2017)₹7,071.50 (Jul 08, 2025)
% from All-Time High-56.59%-17.61%
Growth Metrics
Quarterly Revenue Growth-0.41%0.14%
Quarterly Earnings Growth-0.71%0.27%
Financial Health
Profit Margin (TTM) i0.18%0.24%
Operating Margin (TTM) i0.09%0.26%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i1.770.03
Cash & Liquidity
Book Value per Share (MRQ)₹562.96₹563.87
Cash per Share (MRQ)₹300.75₹132.86
Operating Cash Flow (TTM) i₹106.44M₹19.67B
Levered Free Cash Flow (TTM) i₹241.56M₹21.91B
Dividends
Last 12-Month Dividend Yield i0.29%0.91%
Last 12-Month Dividend i₹1.50₹60.00

Valuation & Enterprise Metrics Analysis: Coral Laboratories vs Divi's Laboratories

MetricCORALABDIVISLAB
Price Ratios
P/E Ratio (TTM) i10.4167.57
Forward P/E i8.98104.19
PEG Ratio i-0.152.55
Price to Sales (TTM) i1.8316.13
Price to Book (MRQ) i0.9310.40
Market Capitalization
Market Capitalization i₹1.98B₹1.61T
Enterprise Value i₹823.11M₹1.52T
Enterprise Value Metrics
Enterprise to Revenue i0.8115.77
Enterprise to EBITDA i4.6449.66
Risk & Other Metrics
Beta i0.700.18
Book Value per Share (MRQ) i₹562.96₹563.87

Financial Statements Comparison: Coral Laboratories vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CORALABDIVISLAB
Revenue/Sales i₹188.21M₹24.10B
Cost of Goods Sold i₹87.37M₹9.56B
Gross Profit i₹100.84M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹17.29M₹6.17B
EBITDA i₹42.30M₹8.48B
Pre-Tax Income i₹37.19M₹7.33B
Income Tax i₹11.55M₹1.88B
Net Income (Profit) i₹25.64M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CORALABDIVISLAB
Cash & Equivalents i₹34.06M₹4.15B
Total Current Assets i₹1.77B₹100.81B
Total Current Liabilities i₹249.58M₹14.52B
Long-Term Debt i₹0₹20.00M
Total Shareholders Equity i₹2.01B₹149.69B
Retained Earnings i₹1.71B₹134.00B
Property, Plant & Equipment i₹217.44M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CORALABDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCORALABDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i622455,187
Average Daily Volume (90 Day) i887395,686
Shares Outstanding i3.57M265.47M
Float Shares i803,040120.77M
% Held by Insiders i0.79%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Coral Laboratories vs Divi's Laboratories

MetricCORALABDIVISLAB
Last 12-Month Dividend i₹1.50₹60.00
Last 12-Month Dividend Yield i0.29%0.91%
3-Year Avg Annual Dividend i₹1.17₹50.00
3-Year Avg Dividend Yield i0.26%0.70%
3-Year Total Dividends i₹3.50₹150.00
Ex-Dividend DateSep 19, 2025Jul 25, 2025